October 23, 2018 PR-M10-18-NI-079
SECAUCUS, N.J. and FLINT, Mich. /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired certain assets of the outreach laboratory services operation of Hurley Medical Center, a leading regional provider of healthcare services.
Patients and providers in central Michigan will have access to Quest's broader range of diagnostic services, a larger network of patient service centers, and access to unique tools, such as the company's Quanum™ suite of healthcare information technologies and data analytics. Financial terms were not disclosed.
"Given Hurley Medical Center's mission of access to care, we struggle with reducing services that we provide," said Melany Gavulic, RN, MBA, President and CEO, Hurley Medical Center. "However, we are fortunate that Quest is in our community and able to continue to provide access and availability for patients seeking cost-efficient Outreach Lab services."
"This acquisition underscores the growing interest of health systems in transitioning their outreach laboratory services to Quest Diagnostics amid mounting reimbursement pressures," said Steve Rusckowski, Chairman, President and CEO of Quest Diagnostics. "Quest has the expertise and scale to drive more value at less cost, and that makes us a strong partner in this changing landscape. With this transaction, we will empower more providers and patients in Michiganand the entire Midwest to access innovative, high value diagnostic services as we also pursue our strategy to accelerate growth."
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.